About
MediBeacon develops fluorescent tracer agents and transdermal detection technology to noninvasively monitor physiological functions, such as kidney function via Glomerular Filtration Rate (GFR) assessment, for clinical and preclinical applications.
Explore MediBeacon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.